Advertisement
Statins are associated with a low risk for side effects

AHA Scientific Statement: Low Risk of Side Effects for Statins

0
Risk for statin-induced serious muscle injury <0.1 percent, newly diagnosed diabetes ~0.2 percent
Veterans Health Administration (VHA) hospitals outperform non-VHA hospitals for 14 of 15 outcome measures in 121 regions

Veterans Health Administration Hospitals Outperform Non-VHAs

0
When 121 regions were considered together, VHA care was better for 14 of 15 outcome measures
Stress related to use of health information technology is common and predictive of burnout among physicians

HIT-Related Stress Linked to Burnout Among Physicians

0
Odds of burnout up with report of poor/marginal time for documentation, time spent on EHR at home
An educational intervention can improve patients' ability to self-manage their chronic diseases

Patient Education Can Improve Chronic Disease Management

0
Improvement seen in patients' ability to manage disease, medical students' ability to educate them
Intraoperative botulinum toxin injections show promise as a way to reduce the risk for postoperative atrial fibrillation following cardiac surgery

Botox Injections Explored to Cut Postop A-Fib in Cardiac Surgery

0
Findings of early trials based on epicardial fat pad injections during cardiac surgery
For individuals with heart failure

Meds Taken Do Not Vary With ADL Impairment in Heart Failure

0
Adults with heart failure with impairment in activities of daily living take as many meds as those without
Nearly two-thirds of insured adults with a previous health care visit did not use an online patient portal in 2017

Most Insured Patients Not Using Online Portals

0
Socioeconomic disparities exist in use of patient portals; privacy concerns cited for nonuse
Pictorial presentation of silent atherosclerosis contributes to the prevention of cardiovascular disease

Pictorial Presentation of Silent Atherosclerosis Helps Cut CV Risk

0
Framingham risk score decreased in intervention group and increased in control group
Rivaroxaban can prevent venous thromboembolism in cancer patients at increased risk

ASH: Rivaroxaban Prevents Blood Clots in At-Risk Cancer Patients

0
Risk for patients in rivaroxaban group reduced during the on-treatment period
There is a J-shaped association for total daily sleep duration with all-cause mortality and cardiovascular events

J-Shaped Association for Sleep Duration, CV Events and Death

0
Both shorter and longer estimated total sleep durations linked to increased risk